Hrt Financial LP Adaptive Biotechnologies Corp Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Hrt Financial LP holds 44,969 shares of ADPT stock, worth $287,351. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,969

Holding current value

$287,351

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.37 - $5.12 $151,545 - $230,241	44,969 New	44,969 $230,000
Q2 2023 Aug 11, 2023	SELL	$6.19 - $8.78 $555,756 - $788,294	-89,783 Reduced 84.76%	16,145 $108,000
Q1 2023 May 12, 2023	SELL	$7.8 - $10.11 $167,091 - $216,576	-21,422 Reduced 16.82%	105,928 $935,000
Q4 2022 Feb 10, 2023	SELL	$6.26 - $9.34 $403,882 - $602,598	-64,518 Reduced 33.63%	127,350 $972,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $133,997 - $261,192	-20,615 Reduced 9.7%	191,868 $1.37 Million
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $30,432 - $70,041	4,755 Added 2.29%	212,483 $1.72 Million
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $2.1 Million - $6 Million	207,728 New	207,728 $2.88 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $2.19 Million - $3.03 Million	-67,955 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $2.53 Million - $4.6 Million	67,955 New	67,955 $2.74 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$192 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$92 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$74.5 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$74.1 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$68 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account